Top

Published in:

01-12-2019 | Metastasis | Clinical Study

Repeat stereotactic radiosurgery for the management of locally recurrent brain metastases

Authors: Christian Iorio-Morin, Rosalie Mercure-Cyr, Gabrielle Figueiredo, Charles Jean Touchette, Laurence Masson-Côté, David Mathieu

Published in: Journal of Neuro-Oncology | Issue 3/2019

Abstract

Purpose

Stereotactic radiosurgery (SRS) is a well-established treatment option for brain metastases (BM). Repeat SRS for progressive BM is an increasingly used paradigm, although little data is available to support this practice. The goal of this study was to assess the safety and efficacy of a second SRS procedure on a previously treated BM.

Methods

We performed a retrospective metastasis-level analysis of patients who underwent two SRS procedures on the same lesion and for whom at least 6 months of radiological follow-up was available. The data collected included patient characteristics, clinical symptoms at time of treatment, SRS parameters, radiological response per RANO-BM criteria, clinical evolution and survival.

Results

Seventy-five BM in 56 patients were included in the analysis. Most frequent primary histologies were non-small-cell lung cancer (59%) and breast cancer (19%). At the second SRS, median treatment volume was 1.19 cc (range 0.07–20.6) treated with a median margin dose of 18 Gy (range 12–20) at the 50% isodose line (range 30–80%). Median follow-up was 11 months. Progression per RANO-BM criteria occurred in 31%, yielding actuarial local control at 1, 2, and 5 years of 68%, 54% and 54% respectively. At last follow-up, 10 patients (18%) had improved relative to the initial presentation, while 21 (38%) were stable and 25 (44%) were deteriorated. Radiation-induced edema and radionecrosis occurred in 8.3% and 5% respectively. The median survival from the diagnosis of BM was 30 months.

Conclusion

Repeat SRS is a safe and effective novel therapeutic approach to consider in carefully selected patients.

Available only for authorised users

Andrews DW, Scott CB, Sperduto PW et al (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363:1665–1672. https://doi.org/10.1016/S0140-6736(04)16250-8 CrossRefPubMed

Aoyama H, Shirato H, Tago M et al (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295:2483–2491. https://doi.org/10.1001/jama.295.21.2483 CrossRefPubMed

Chang EL, Wefel JS, Hess KR et al (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10:1037–1044. https://doi.org/10.1016/S1470-2045(09)70263-3 CrossRefPubMed

Brown PD, Ballman KV, Cerhan JH et al (2017) Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial. Lancet Oncol 18:1049–1060. https://doi.org/10.1016/S1470-2045(17)30441-2 CrossRefPubMedPubMedCentral

Ammirati M, Cobbs CS, Linskey ME et al (2010) The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 96:85–96. https://doi.org/10.1007/s11060-009-0055-6 CrossRefPubMed

Hong CS, Deng D, Vera A, Chiang VL (2019) Laser-interstitial thermal therapy compared to craniotomy for treatment of radiation necrosis or recurrent tumor in brain metastases failing radiosurgery. J Neurooncol 142:309–317. https://doi.org/10.1007/s11060-019-03097-z CrossRefPubMed

Terakedis BE, Jensen RL, Boucher K, Shrieve DC (2014) Tumor control and incidence of radiation necrosis after reirradiation with stereotactic radiosurgery for brain metastases. J Radiosurg SBRT 3:21–28PubMedPubMedCentral

Jayachandran P, Shultz D, Modlin L et al (2014) Repeat stereotactic radiosurgery (SRS) for brain metastases locally recurrent following initial SRS. Int J Radiat Oncol Biol Phys 90:S320. https://doi.org/10.1016/j.ijrobp.2014.05.1063 CrossRef

Trifiletti DM, Patel NV, Sheehan JP (2015) Repeated stereotactic radiosurgery for intracranial metastases after local failure: the safety and efficacy of repeat radiosurgery. Int J Radiat Oncol Biol Phys 93:E73. https://doi.org/10.1016/j.ijrobp.2015.07.729 CrossRef

10.

Minniti G, Scaringi C, Paolini S et al (2016) Repeated stereotactic radiosurgery for patients with progressive brain metastases. J Neurooncol 126:91–97. https://doi.org/10.1007/s11060-015-1937-4 CrossRefPubMed

11.

Koffer P, Chan J, Rava P et al (2017) Repeat stereotactic radiosurgery for locally recurrent brain metastases. World Neurosurg 104:589–593. https://doi.org/10.1016/j.wneu.2017.04.103 CrossRefPubMed

12.

McKay WH, McTyre ER, Okoukoni C et al (2017) Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery. J Neurosurg 127:148–156. https://doi.org/10.3171/2016.5.JNS153051 CrossRefPubMed

13.

Moreau J, Khalil T, Dupic G et al (2018) Second course of stereotactic radiosurgery for locally recurrent brain metastases: Safety and efficacy. PLoS ONE 13:e0195608. https://doi.org/10.1371/journal.pone.0195608 CrossRefPubMedPubMedCentral

14.

Lin NU, Lee EQ, Aoyama H et al (2015) Response assessment criteria for brain metastases: proposal from the RANO group. Lancet Oncol 16:e270–e278. https://doi.org/10.1016/S1470-2045(15)70057-4 CrossRefPubMed

15.

Solberg TD, Balter JM, Benedict SH et al (2012) Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy: executive summary. Pract Radiat Oncol 2:2–9. https://doi.org/10.1016/j.prro.2011.06.014 CrossRefPubMedPubMedCentral

16.

Soon YY, Tham IWK, Lim KH et al (2014) Surgery or radiosurgery plus whole brain radiotherapy versus surgery or radiosurgery alone for brain metastases. Cochrane Database Syst Rev 295:CD009454. https://doi.org/10.1002/14651858.CD009454.pub2 CrossRef

17.

Brown PD, Jaeckle K, Ballman KV et al (2016) Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial. JAMA 316:401–409. https://doi.org/10.1001/jama.2016.9839 CrossRefPubMedCentral

18.

Iorio-Morin C, Masson-Côté L, Ezahr Y et al (2014) Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control. J Neurosurg 121(Suppl 2):69–74. https://doi.org/10.3171/2014.7.GKS141488 CrossRefPubMed

19.

Yamamoto M, Serizawa T, Shuto T et al (2014) Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol 15:387–395. https://doi.org/10.1016/S1470-2045(14)70061-0 CrossRefPubMed

20.

Lucas JT, Colmer HG, White L et al (2015) Competing risk analysis of neurologic versus nonneurologic death in patients undergoing radiosurgical salvage after whole-brain radiation therapy failure: who actually dies of their brain metastases? Int J Radiat Oncol Biol Phys 92:1008–1015. https://doi.org/10.1016/j.ijrobp.2015.04.032 CrossRefPubMedPubMedCentral

21.

Shehata WM, Hendrickson FR, Hindo WA (1974) Rapid fractionation technique and re-treatment of cerebral metastases by irradiation. Cancer 34:257–261CrossRef

22.

Iorio-Morin C, Liscak R, Vladyka V et al (2018) Repeat stereotactic radiosurgery for progressive or recurrent vestibular schwannomas. Neurosurgery 19:v1. https://doi.org/10.1093/neuros/nyy416 CrossRef

23.

Cohen-Inbar O, Tata A, Moosa S et al (2018) Stereotactic radiosurgery in the treatment of parasellar meningiomas: long-term volumetric evaluation. J Neurosurg 128:362–372. https://doi.org/10.3171/2016.11.JNS161402 CrossRefPubMed

Title: Repeat stereotactic radiosurgery for the management of locally recurrent brain metastases
Authors: Christian Iorio-Morin
Rosalie Mercure-Cyr
Gabrielle Figueiredo
Charles Jean Touchette
Laurence Masson-Côté
David Mathieu
Publication date: 01-12-2019
Publisher: Springer US
Keyword: Metastasis
Published in: Journal of Neuro-Oncology / Issue 3/2019
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-019-03323-8

At a glance: The STEP trials

Springer Medicine

Repeat stereotactic radiosurgery for the management of locally recurrent brain metastases

Abstract

Purpose

Methods

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 3/2019

Increased 14C-acetate accumulation in IDH-mutated human glioblastoma: implications for detecting IDH-mutated glioblastoma with 11C-acetate PET imaging

Mortality patterns in long-term survivors of childhood or adolescent central nervous system tumour in Sweden

Shortened ex vivo manufacturing time of EGFRvIII-specific chimeric antigen receptor (CAR) T cells reduces immune exhaustion and enhances antiglioma therapeutic function

Correction to: Efficacy of Dabrafenib for three children with brainstem BRAFV600E positive ganglioglioma

Analysis of intra-operative variables as predictors of 30-day readmission in patients undergoing glioma surgery at a single center

White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximab